Morgan Stanley’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Morgan Stanley’s Portfolio GBIM Stock Details GBIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,011	Closed	-$3K	–	6880
2015 Q2	$3K	Sell	1,011 -999	-50%	-$6.22K	﹤0.01%	6491
2015 Q1	$15K	Buy	2,010 +10	+0.5%	+$72	﹤0.01%	6138
2014 Q4	$15K	Sell	2,000 -10	-0.5%	-$70	﹤0.01%	6128
2014 Q3	$14K	Buy	+2,010	New	+$20.6K	﹤0.01%	6113

Other funds holding GBIM

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

CWM

Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley's GBIM Position: Q3 2015 in Review

Morgan Stanley sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q3 2015, closing a stake of 1,011 shares — an estimated $3K sold.

Morgan Stanley first reported a position in GBIM in Q3 2014 and held it in 4 quarters. The position peaked at $15K in Q1 2015. 7 funds tracked by Wall St. Rank hold GBIM as of Q3 2015.

Morgan Stanley reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
Morgan Stanley sold 1,011 GLOBEIMMUNE INC COM STK (DE) shares in Q3 2015, an estimated $3K.
Morgan Stanley first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q3 2014 and held it in 4 quarters.
Morgan Stanley's GLOBEIMMUNE INC COM STK (DE) position peaked at $15K in Q1 2015.
7 funds tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q3 2015.

Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.